Benoit Gamain

Title: Benoit Gamain: Innovator in Malaria Research

Introduction

Benoit Gamain is a prominent inventor based in Washington, DC, known for his significant contributions to malaria research. His work focuses on understanding the mechanisms of Plasmodium falciparum, the parasite responsible for the most severe form of malaria. Through his innovative research, he aims to develop new strategies for combating this deadly disease.

Latest Patents

Benoit Gamain holds a patent titled "Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A." This invention relates to the discovery of a var gene and corresponding protein that modulates the adhesion of parasitized red blood cells to chondroitin sulfate A. The patent also discloses novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use related to this discovery. He has 1 patent to his name.

Career Highlights

Benoit Gamain is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this esteemed institution allows him to collaborate with leading scientists and researchers in the field of infectious diseases. His work has been instrumental in advancing our understanding of malaria and developing potential treatments.

Collaborations

Throughout his career, Benoit has worked alongside notable colleagues, including Artur Scherf and Louis H. Miller. These collaborations have enriched his research and contributed to the broader scientific community's efforts to combat malaria.

Conclusion

Benoit Gamain's innovative research and patent contributions are vital in the fight against malaria. His work not only enhances our understanding of the disease but also paves the way for new therapeutic approaches.